These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31450507)

  • 1. Impaired Isometric Force Matching in Upper and Lower Limbs Revealed by Quantitative Motor Assessments in Huntington's Disease.
    Medzech S; Sass C; Bohlen S; Lange HW; Koch R; Schubert R; Ringelstein EB; Reilmann R
    J Huntingtons Dis; 2019; 8(4):483-492. PubMed ID: 31450507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease.
    Reilmann R; Bohlen S; Klopstock T; Bender A; Weindl A; Saemann P; Auer DP; Ringelstein EB; Lange HW
    Mov Disord; 2010 Oct; 25(13):2195-202. PubMed ID: 20645403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grasping premanifest Huntington's disease - shaping new endpoints for new trials.
    Reilmann R; Bohlen S; Klopstock T; Bender A; Weindl A; Saemann P; Auer DP; Ringelstein EB; Lange HW
    Mov Disord; 2010 Dec; 25(16):2858-62. PubMed ID: 20818671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Objective assessment of progression in Huntington's disease: a 3-year follow-up study.
    Reilmann R; Kirsten F; Quinn L; Henningsen H; Marder K; Gordon AM
    Neurology; 2001 Sep; 57(5):920-4. PubMed ID: 11552034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor outcome measures in Huntington disease clinical trials.
    Reilmann R; Schubert R
    Handb Clin Neurol; 2017; 144():209-225. PubMed ID: 28947119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Objective assessment of gait and posture in premanifest and manifest Huntington disease - A multi-center study.
    Beckmann H; Bohlen S; Saft C; Hoffmann R; Gerss J; Muratori L; Ringelstein EB; Landwehrmeyer GB; Reilmann R
    Gait Posture; 2018 May; 62():451-457. PubMed ID: 29660633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tapping linked to function and structure in premanifest and symptomatic Huntington disease.
    Bechtel N; Scahill RI; Rosas HD; Acharya T; van den Bogaard SJ; Jauffret C; Say MJ; Sturrock A; Johnson H; Onorato CE; Salat DH; Durr A; Leavitt BR; Roos RA; Landwehrmeyer GB; Langbehn DR; Stout JC; Tabrizi SJ; Reilmann R
    Neurology; 2010 Dec; 75(24):2150-60. PubMed ID: 21068430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of quantitative oculometry in the assessment of Huntington's disease.
    Ali FR; Michell AW; Barker RA; Carpenter RH
    Exp Brain Res; 2006 Feb; 169(2):237-45. PubMed ID: 16273398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers.
    Vaccarino AL; Anderson K; Borowsky B; Duff K; Giuliano J; Guttman M; Ho AK; Orth M; Paulsen JS; Sills T; van Kammen DP; Evans KR;
    Mov Disord; 2011 Apr; 26(5):877-84. PubMed ID: 21370269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gait variability as digital biomarker of disease severity in Huntington's disease.
    Gaßner H; Jensen D; Marxreiter F; Kletsch A; Bohlen S; Schubert R; Muratori LM; Eskofier B; Klucken J; Winkler J; Reilmann R; Kohl Z
    J Neurol; 2020 Jun; 267(6):1594-1601. PubMed ID: 32048014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordination of fingertip forces during precision grip in premanifest Huntington's disease.
    Rao AK; Gordon AM; Marder KS
    Mov Disord; 2011 Apr; 26(5):862-9. PubMed ID: 21394785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of hand-held dynamometry in the evaluation of lower limb muscle strength in people with Huntington's disease.
    Busse ME; Hughes G; Wiles CM; Rosser AE
    J Neurol; 2008 Oct; 255(10):1534-40. PubMed ID: 19005627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of dual-task cognitive interference on gait and turning in Huntington's disease.
    Purcell NL; Goldman JG; Ouyang B; Liu Y; Bernard B; O'Keefe JA
    PLoS One; 2020; 15(1):e0226827. PubMed ID: 31910203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor overflow in Huntington's disease.
    Georgiou-Karistianis N; Hoy KE; Bradshaw JL; Farrow M; Chiu E; Churchyard A; Fitzgerald PB; Armatas CA
    J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):904-6. PubMed ID: 15146012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective analysis of hand tapping as a longitudinal marker of disease progression in Huntington's disease.
    Collins LM; Lazic SE; Barker RA
    BMC Neurol; 2014 Feb; 14():35. PubMed ID: 24564568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up study.
    Youssov K; Dolbeau G; Maison P; Boissé MF; Cleret de Langavant L; Roos RA; Bachoud-Lévi AC
    Mov Disord; 2013 Dec; 28(14):1995-2001. PubMed ID: 24123464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of functional decline in Huntington's disease. Huntington Study Group.
    Marder K; Zhao H; Myers RH; Cudkowicz M; Kayson E; Kieburtz K; Orme C; Paulsen J; Penney JB; Siemers E; Shoulson I
    Neurology; 2000 Jan; 54(2):452-8. PubMed ID: 10668713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unified Huntington's disease rating scale for advanced patients: validation and follow-up study.
    Youssov K; Dolbeau G; Maison P; Boissé MF; Cleret de Langavant L; Roos RA; Bachoud-Lévi AC
    Mov Disord; 2013 Oct; 28(12):1717-23. PubMed ID: 24166899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of involuntary choreatic movements in Huntington's disease--toward objective and quantitative measures.
    Reilmann R; Bohlen S; Kirsten F; Ringelstein EB; Lange HW
    Mov Disord; 2011 Oct; 26(12):2267-73. PubMed ID: 21661053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.